date,title,source
Oct-23-18,KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multiple Indications,GlobeNewswire
Oct-24-18,KemPharm Presents Data from Intranasal and Intravenous Human Abuse Potential Trials of KP415 Prodrug at the American Academy of Child & Adolescent Psychiatry Meeting,GlobeNewswire
Nov-01-18,KemPharm to Report Third Quarter 2018 Results,GlobeNewswire
